Literature DB >> 6197198

In vivo interactions of acrylonitrile with macromolecules in rats.

M Y Farooqui, A E Ahmed.   

Abstract

The irreversible binding of [2,3-14C]acrylonitrile (VCN) to proteins, RNA and DNA of various tissues of male Sprague-Dawley rats after a single oral dose of 46.5 mg/kg (0.5 LD50) has been studied. Proteins were isolated by chloroform-isoamyl alcohol-phenol extraction. RNA and DNA were separated by hydroxyapatite chromatography. Binding of VCN to proteins was extensive and was time dependent. Radioactivity in nucleic acids was registered in the liver and the target organs, stomach and brain. DNA alkylation, which increased by time, was significantly higher in the target organs, brain and stomach (119 and 81 pmol/mg, respectively, at 24 h) than that in the liver. The covalent binding indices for the liver, stomach and brain at 24 h after dosing were, 5.9, 51.9 and 65.3, respectively. These results suggest that VCN is able to act as a multipotent carcinogen by alkylation of DNA in the extrahepatic target tissues, stomach and brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197198     DOI: 10.1016/0009-2797(83)90170-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

1.  Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.

Authors:  Christine Juliana; Teresa Fernandes-Alnemri; Jianghong Wu; Pinaki Datta; Leobaldo Solorzano; Je-Wook Yu; Rong Meng; Andrew A Quong; Eicke Latz; Charles P Scott; Emad S Alnemri
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

2.  Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens.

Authors:  W K Lutz
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  DNA adducts of halogenated hydrocarbons.

Authors:  H M Bolt; R J Laib; H Peter; H Ottenwälder
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.